Abbott's SIMCOR Receives FDA Approval for New Dosage Strengths
The new SIMCOR dosage strengths combine 40 mg of simvastatin – the most commonly prescribed dose of simvastatin – with either 500 mg or 1,000 mg of niacin extended-release. SIMCOR is the first treatment to combine Abbott's proprietary niacin extended-release and simvastatin, the most commonly used statin.
SIMCOR is a prescription medication used along with diet in people who cannot control their cholesterol levels by diet and exercise alone. SIMCOR is approved to raise HDL "good" cholesterol and lower levels of elevated total cholesterol, LDL "bad" cholesterol and triglycerides.
SIMCOR is a combination medicine used when treatment with simvastatin alone or niacin extended-release alone is not considered adequate. No additional benefit of SIMCOR on heart disease over and above that shown for simvastatin alone and niacin alone has been demonstrated.
Source: Abbott
